Subscribe

Horizon Kinetics Medical ETF (MEDX)

USD35.50 -0.19 (-0.53%)
NASDAQ USD US Equity
NAV USD 35.66 -0.45% vs NAV as of 2026-07-12
AUM USD 18.54M
TER 0.85%
Yield (TTM) 1.15%
Distribution Distributing · Annual
52-week range 27.15 – 37.69
Holdings 34
Issuer Horizon Kinetics

About this ETF

The Horizon Kinetics Medical ETF (the “Fund”) seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund (“ETF”) that will invest primarily in patented first line pharmaceuticals and biologics as these products tend to have high profit margins and significant barriers to entry. The Fund employs a long-term perspective, seeking to capture returns of both intrinsic valuation realization and scientific discovery.

ISIN US53656G5633
Issuer Horizon Kinetics
Domicile US
Inception 2023-01-26
Asset class Equity

Price

Top 10 holdings

Eli Lilly & Co LLY 18.82%
AbbVie Inc ABBV 8.98%
US BANK MMDA - USBGFS 7 06/01/2031 7.48%
Novartis AG NVS 6.97%
Johnson & Johnson JNJ 5.82%
Alkermes PLC ALKS 5.64%
AstraZeneca PLC AZN 4.64%
Bristol-Myers Squibb Co BMY 4.55%
Amgen Inc AMGN 4.04%
Merck & Co Inc MRK 3.91%
See full holdings →